Abstract
Purpose
Mucosal melanoma of the head and neck is a rare entity with a poor prognosis. Sinonasal tract is a common occurrence site for this malignancy. The aim of this study is to provide an analysis of 25 patients diagnosed with sinonasal mucosal melanoma (SNMM) treated in a single institution.
Patients and methods
The medical charts of 25 SNMM patients without distant metastasis treated from 1996 to 2007 were reviewed. Patients were re-staged according to the 7th edition of American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system for head and neck melanoma. Fourteen and 11 patients were diagnosed with T3 or T4 disease, respectively. Three patients had lymph node metastasis at diagnosis. Surgical resection was performed in 21 patients (84 %), and adjuvant radiation therapy was given to all patients except for one. Several patients also received chemotherapy or biological treatment.
Results
The 5-year local-regional control (LRC) rate was 54 %. The 5-year overall survival (OS) and disease-free survival (DFS) rates were 41 and 38 %, respectively. Recurrences were observed in 10 patients and distal failures in 9 cases. On univariate analysis, locally advanced stage (IV) was a poor prognostic factor for OS and DFS (P < 0.05). In addition, patients diagnosed with T4 lesions had significantly reduced local-regional control as compared to those with T3 diseases (18 vs. 77 %, P = 0.02). Multivariate analysis revealed that T classification was the only significant factor for local-regional control.
Conclusion
SNMM is a devastating tumor, with high risk for local failure as well as distant metastases. The stage of the primary disease, i.e., the extent of tumor infiltration, is the predominant factor influencing the prognosis. OS and DFS after surgery followed by radiation therapy remain suboptimal. Further researches for novel treatment strategies such as targeted therapy are necessary to improve the outcomes.
Similar content being viewed by others
References
Roth TN, Gengler C, Huber GF, Holzmann D (2010) Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 32:1385–1392
Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V (2012) Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 5:739–753
Gavriel H, McArthur G, Sizaland A, Henderson M (2011) Review: mucosal melanoma of the head and neck. Melanoma Res 21:257–266
Khademi B, Bahranifard H, Nasrollahi H, Mohammadianpanah M (2011) Primary mucosal melanoma of the sinonasal tract: report of 18 patients and analysis of 1077 patients in the literature. Braz J Otorhinolaryngol 77:58–64
Benlyazid A, Thariat J, Temam S, Malard O, Florescu C, Choussy O et al (2010) Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg 136:1219–1225
Pathel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH et al (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck 24:247–257
Wu AJ, Gomez J, Zhung JE, Chan K, Gomez DR, Wolden SL et al (2010) Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 33:281–285
Bachar G, Loh KS, O’sullivan B, Goldstein D, Wood S, Brown D et al (2008) Mucosal melanomas of the head and neck: the Princess Margaret Hospital experience. Head Neck 30:1325–1331
Krengli M, Masinin L, Kaanders JH, Maingon P, Oei SB, Zouhair A et al (2006) Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys 65:751–759
Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F et al (2005) Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 103:313–319
Narasimhan K, Kucuk O, Lin HS, Heilbrun LK, Carron M, Venkatramanamoorthy R et al (2009) Sinonasal mucosal melanoma: a 13-year experience at a single institution. Skull Base 19:255–262
Shuman AG, Light E, Olsen SH, Pynnonen MA, Taylor JM, Johnson TM et al (2011) Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 137:331–337
Owens JM, Roberts DB, Myers JN (2003) The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 129:864–868
Khan N, Khan MK, Almasan A, Singh AD, Macklis R (2011) The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys 80:645–654
Chan RC, Chan JY, Wei WI (2012) Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital. Laryngoscope 122:2749–2753
Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M et al (2010) Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center. Cancer 116:2215–2223
Vandenhende C, Leroy X, Chevalier D, Mortuaire G (2012) Sinonasal mucosal melanoma: retrospective survival study of 25 patients. J Laryngol Otol 126:147–151
Thariat J, Poissonnet G, Marcy PY, Lattes L, Butori C, Guevara N et al (2011) Effect of surgical modality and hypofractionated split-course radiotherapy on local control and survival from sinonasal mucosal melanoma. Clin Oncol 23:579–586
Lund VJ, Chisholm EJ, Howard DJ, Wei WI (2012) Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 50:203–210
Clifton N, Harrison L, Bradley PJ, Jones NS (2011) Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol 125:479–485
Manolidis S, Donald PJ (1997) Malignant mucosal melanoma of the head and neck: reviews of the literature and report of 14 patients. Cancer 80:1373–1386
Blake PR, Catterall M, Errington RD (1985) Treatment of malignant melanoma by fast neutrons. Br J Surg 72:517–519
Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T et al (2009) Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 74:15–20
Sasse AD, Sasse EC, Clark LG, Ulloa L, Clark OA (2007) Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database Syst Rev CD005413
Kasper B, D’Hondt V, Vereecken P, Awada A (2007) Novel treatment strategies for malignant melanoma: a new beginning? Crit Rev Oncol Hematol 621:16–22
Nashan D, Muller ML, Grabbe S, Wustlich S, Enk A (2007) Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine. J Eur Acad Dermatol Venereol 21:1305–1318
Hodi FS, Friedlander P, Corless CL, Heinrich MC, Mac Rae S, Kruse A et al (2008) Major response to imatinib mesylate in KIT-mutated melanoma. J Clin Oncol 26:2046–2051
Satzqer I, Kuttler U, Volker B, Schenck F, Kapp A, Gutzmer R (2010) Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy—case report and review of literature. Dermatology 220:77–81
Minor DR, Kashani-Sabet M, Garrido M, O’Day SJ, Hamid O, Bastian BC (2012) Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res 18:1457–1463
Ethical standards
This article does not contain any studies with human or animal subjects performed by any of the authors.
Statement of informed consent
Owing to the retrospective nature of this chart review study and reporting of non-protected health information, the institutional review boards approved this study with exemption for retrospective acquisition of informed consent.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shen, C., Xu, T., Kong, L. et al. Outcomes of primary mucosal melanoma originated from sinonasal tract. J Radiat Oncol 4, 243–247 (2015). https://doi.org/10.1007/s13566-015-0202-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-015-0202-y